NeueHealth (NYSE:NEUE) Trading Up 1.3% - Should You Buy?

Shares of NeueHealth, Inc. (NYSE:NEUE - Get Free Report) were up 1.3% during trading on Tuesday . The stock traded as high as $6.65 and last traded at $6.58. Approximately 2,225 shares traded hands during mid-day trading, a decline of 89% from the average daily volume of 20,469 shares. The stock had previously closed at $6.49.

NeueHealth Trading Down 2.4 %

The company has a 50 day moving average of $6.56 and a 200 day moving average of $6.26. The firm has a market cap of $55.01 million, a price-to-earnings ratio of -0.13 and a beta of 0.54.

NeueHealth (NYSE:NEUE - Get Free Report) last announced its quarterly earnings results on Thursday, March 20th. The company reported ($7.41) EPS for the quarter, missing the consensus estimate of ($2.29) by ($5.12). The company had revenue of $232.64 million during the quarter, compared to analyst estimates of $261.80 million. NeueHealth had a negative net margin of 36.28% and a negative return on equity of 6.40%. As a group, sell-side analysts anticipate that NeueHealth, Inc. will post -9.13 EPS for the current fiscal year.

Insider Activity at NeueHealth

In other NeueHealth news, CEO George Lawrence Mikan III sold 13,180 shares of the business's stock in a transaction on Wednesday, March 12th. The stock was sold at an average price of $6.93, for a total value of $91,337.40. Following the transaction, the chief executive officer now owns 297,790 shares of the company's stock, valued at approximately $2,063,684.70. The trade was a 4.24 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Jay Matushak sold 4,448 shares of the business's stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $6.74, for a total value of $29,979.52. Following the completion of the transaction, the chief financial officer now directly owns 41,592 shares in the company, valued at approximately $280,330.08. This represents a 9.66 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 68,178 shares of company stock valued at $467,763 in the last 90 days. 64.30% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On NeueHealth

A hedge fund recently bought a new stake in NeueHealth stock. Virtu Financial LLC bought a new position in shares of NeueHealth, Inc. (NYSE:NEUE - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund bought 10,232 shares of the company's stock, valued at approximately $76,000. Virtu Financial LLC owned about 0.12% of NeueHealth as of its most recent SEC filing. 63.88% of the stock is currently owned by hedge funds and other institutional investors.

About NeueHealth

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.